Parnell Pharmaceuticals Holdings Profit Margin 2014-2018 | PARNF
Current and historical gross margin, operating margin and net profit margin for Parnell Pharmaceuticals Holdings (PARNF) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Parnell Pharmaceuticals Holdings net profit margin as of June 30, 2018 is 0%.
| Parnell Pharmaceuticals Holdings Annual Profit Margins |
| Parnell Pharmaceuticals Holdings Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.
|
